Multiple Sclerosis Patients Doing Well Years After Stem Cell Transplants
Friday, January 2, 2015 - 12:40
in Health & Medicine
Multiple sclerosis is a degenerative disease and most patients with RRMS who received disease-modifying therapies experience breakthrough disease. Autologous (using a patient's own cells) hematopoietic cell transplant (HCT) has been studied in multiple sclerosis with the goal of removing disease-causing immune cells and resetting the immune system. read more